News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Phadia AB Introduces ImmunoCAP(R) Molecular Allergy and Two New Fully Automated, High Throughput Instrument Platforms at the American Association for Clinical Chemistry Annual Meeting


7/25/2011 10:49:14 AM

ATLANTA--(BUSINESS WIRE)--Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES